Elan to exercise ATS option

ELAN Corporation is to exercise its option to acquire 100 per cent of the outstanding stock of Advanced Therapeutic Systems (…

ELAN Corporation is to exercise its option to acquire 100 per cent of the outstanding stock of Advanced Therapeutic Systems (ATS) at $36 (£22) per share at a total cost of $141 million. The transaction will be completed before the end of October and Elan will incur a one time charge of about $141 million in the quarter to September, 1996. ATS was formed in May 1993 and subsequently funded through a rights offering to Elan shareholders.

  • Join The Irish Times on WhatsApp and stay up to date

  • Sign up to the Business Today newsletter for the latest new and commentary in your inbox

  • Listen to Inside Business podcast for a look at business and economics from an Irish perspective